89 related articles for article (PubMed ID: 11911945)
1. Radicicol represses the transcriptional function of the estrogen receptor by suppressing the stabilization of the receptor by heat shock protein 90.
Lee MO; Kim EO; Kwon HJ; Kim YM; Kang HJ; Kang H; Lee JE
Mol Cell Endocrinol; 2002 Feb; 188(1-2):47-54. PubMed ID: 11911945
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
[TBL] [Abstract][Full Text] [Related]
3. Ligand-independent and agonist-mediated degradation of estrogen receptor-alpha in breast carcinoma cells: evidence for distinct degradative pathways.
Nonclercq D; Journé F; Body JJ; Leclercq G; Laurent G
Mol Cell Endocrinol; 2004 Nov; 227(1-2):53-65. PubMed ID: 15501584
[TBL] [Abstract][Full Text] [Related]
4. Reduction of hypoxia-induced transcription through the repression of hypoxia-inducible factor-1alpha/aryl hydrocarbon receptor nuclear translocator DNA binding by the 90-kDa heat-shock protein inhibitor radicicol.
Hur E; Kim HH; Choi SM; Kim JH; Yim S; Kwon HJ; Choi Y; Kim DK; Lee MO; Park H
Mol Pharmacol; 2002 Nov; 62(5):975-82. PubMed ID: 12391259
[TBL] [Abstract][Full Text] [Related]
5. The 90 kDa heat-shock protein (hsp90) modulates the binding of the oestrogen receptor to its cognate DNA.
Sabbah M; Radanyi C; Redeuilh G; Baulieu EE
Biochem J; 1996 Feb; 314 ( Pt 1)(Pt 1):205-13. PubMed ID: 8660284
[TBL] [Abstract][Full Text] [Related]
6. Thyroid hormone is an inhibitor of estrogen-induced degradation of estrogen receptor-alpha protein: estrogen-dependent proteolysis is not essential for receptor transactivation function in the pituitary.
Alarid ET; Preisler-Mashek MT; Solodin NM
Endocrinology; 2003 Aug; 144(8):3469-76. PubMed ID: 12865327
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia induces proteasome-dependent degradation of estrogen receptor alpha in ZR-75 breast cancer cells.
Stoner M; Saville B; Wormke M; Dean D; Burghardt R; Safe S
Mol Endocrinol; 2002 Oct; 16(10):2231-42. PubMed ID: 12351689
[TBL] [Abstract][Full Text] [Related]
8. Hormone-dependent transactivation by estrogen receptor chimeras that do not interact with hsp90. Evidence for transcriptional repressors.
Lee HS; Aumais J; White JH
J Biol Chem; 1996 Oct; 271(42):25727-30. PubMed ID: 8824196
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic radicicol binds to the N-terminal domain of Hsp90 and shares important biologic activities with geldanamycin.
Schulte TW; Akinaga S; Soga S; Sullivan W; Stensgard B; Toft D; Neckers LM
Cell Stress Chaperones; 1998 Jun; 3(2):100-8. PubMed ID: 9672245
[TBL] [Abstract][Full Text] [Related]
10. Stereospecific antitumor activity of radicicol oxime derivatives.
Soga S; Sharma SV; Shiotsu Y; Shimizu M; Tahara H; Yamaguchi K; Ikuina Y; Murakata C; Tamaoki T; Kurebayashi J; Schulte TW; Neckers LM; Akinaga S
Cancer Chemother Pharmacol; 2001 Dec; 48(6):435-45. PubMed ID: 11800023
[TBL] [Abstract][Full Text] [Related]
11. Search for Hsp90 inhibitors with potential anticancer activity: isolation and SAR studies of radicicol and monocillin I from two plant-associated fungi of the Sonoran desert.
Turbyville TJ; Wijeratne EM; Liu MX; Burns AM; Seliga CJ; Luevano LA; David CL; Faeth SH; Whitesell L; Gunatilaka AA
J Nat Prod; 2006 Feb; 69(2):178-84. PubMed ID: 16499313
[TBL] [Abstract][Full Text] [Related]
12. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
Marsaud V; Gougelet A; Maillard S; Renoir JM
Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
[TBL] [Abstract][Full Text] [Related]
13. Distinct regulation of insulin receptor substrate-1 and -2 by 90-kDa heat-shock protein in adrenal chromaffin cells.
Yoshikawa N; Nemoto T; Satoh S; Maruta T; Yanagita T; Chosa E; Wada A
Neurochem Int; 2010 Jan; 56(1):42-50. PubMed ID: 19737590
[TBL] [Abstract][Full Text] [Related]
14. Classification of breast cancer cells on the basis of a functional assay for estrogen receptor.
Biswas DK; Averboukh L; Sheng S; Martin K; Ewaniuk DS; Jawde TF; Wang F; Pardee AB
Mol Med; 1998 Jul; 4(7):454-67. PubMed ID: 9713824
[TBL] [Abstract][Full Text] [Related]
15. KF25706, a novel oxime derivative of radicicol, exhibits in vivo antitumor activity via selective depletion of Hsp90 binding signaling molecules.
Soga S; Neckers LM; Schulte TW; Shiotsu Y; Akasaka K; Narumi H; Agatsuma T; Ikuina Y; Murakata C; Tamaoki T; Akinaga S
Cancer Res; 1999 Jun; 59(12):2931-8. PubMed ID: 10383157
[TBL] [Abstract][Full Text] [Related]
16. Radicicol potentiates heat-induced cell killing in a human oesophageal cancer cell line: the Hsp90 chaperone complex as a new molecular target for enhancement of thermosensitivity.
Akimoto T; Nonaka T; Harashima K; Sakurai H; Ishikawa H; Mitsuhashi N
Int J Radiat Biol; 2004 Jul; 80(7):483-92. PubMed ID: 15360086
[TBL] [Abstract][Full Text] [Related]
17. pS2 Gene expression in HepG2 cells: complex regulation through crosstalk between the estrogen receptor alpha, an estrogen-responsive element, and the activator protein 1 response element.
Barkhem T; Haldosén LA; Gustafsson JA; Nilsson S
Mol Pharmacol; 2002 Jun; 61(6):1273-83. PubMed ID: 12021387
[TBL] [Abstract][Full Text] [Related]
18. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
Chien PY; Ito M; Park Y; Tagami T; Gehm BD; Jameson JL
Mol Endocrinol; 1999 Dec; 13(12):2122-36. PubMed ID: 10598586
[TBL] [Abstract][Full Text] [Related]
19. Development of radicicol analogues.
Soga S; Shiotsu Y; Akinaga S; Sharma SV
Curr Cancer Drug Targets; 2003 Oct; 3(5):359-69. PubMed ID: 14529387
[TBL] [Abstract][Full Text] [Related]
20. Role of HSP90 in mediating cross-talk between the estrogen receptor and the Ah receptor signal transduction pathways.
Caruso JA; Laird DW; Batist G
Biochem Pharmacol; 1999 Nov; 58(9):1395-403. PubMed ID: 10513983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
